Skip to main content

. 1968 Jun;43(229):340–343. doi: 10.1136/adc.43.229.340

Desferrioxamine in thalassaemia.

M Diwany, M Gabr, A el Hefni, N Mokhtar

PMCID: PMC2019950 PMID: 5652711

340

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Bannerman R. M., Callender S. T., Williams D. L. Effect of Desferrioxamine and D.T.P.A. in Iron Overload. Br Med J. 1962 Dec 15;2(5319):1573–1577. doi: 10.1136/bmj.2.5319.1573. [DOI] [PMC free article] [PubMed] [Google Scholar]
McDonald R. Deferoxamine and diethylenetriaminepentaacetic acid (DTPA) in thalassemia. J Pediatr. 1966 Oct;69(4):563–571. doi: 10.1016/s0022-3476(66)80041-0. [DOI] [PubMed] [Google Scholar]
NIELSEN J. B. Influence of desferrioxamine on the renal excretion of iron. Preliminary report. Acta Med Scand. 1963 Apr;173:499–504. doi: 10.1111/j.0954-6820.1963.tb17433.x. [DOI] [PubMed] [Google Scholar]
SANTOS A. S., PISCIOTTA A. V. ACUTE IRON INTOXICATION. TREATMENT WITH DESFERRIOXAMINE (BA-29837). Am J Dis Child. 1964 Apr;107:424–427. [PubMed] [Google Scholar]
STEVENS E., ROSOFF B., WEINER M., SPENCER H. Metabolism of the chelating agent diethylenetriamine pentaacetic acid (C14DTPA) in man. Proc Soc Exp Biol Med. 1962 Nov;111:235–238. doi: 10.3181/00379727-111-27752. [DOI] [PubMed] [Google Scholar]
WOEHLER F. THE TREATMENT OF HAEMOCHROMATOSIS WITH DESFERRIOXAMINE. Acta Haematol. 1963 Aug;30:65–87. doi: 10.1159/000208110. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES